Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain

Pigment Cell Research

Volumn 15, Issue 1, 2002, Pages 67-75

  Iwakura, Masaki ^a   Kondoh, Hirofumi ^b,c   Hiratsuka, Junichi ^d   Ehara, Kazumasa ^a   Tamaki, Norihiko ^a   Mishima, Yutaka ^b  

^a KOBE UNIVERSITY   (Japan)

^b Mishima Institute for Dermatological Research   (Japan)

^c Bio Research Inc   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

10B boronophenylalanine; Amelanotic melanoma; Boron neutron capture therapy; Melanoma brain metastasis

Indexed keywords

ANIMALIA;

4 BORONOPHENYLALANINE; 4-BORONOPHENYLALANINE; BORON; BORON DERIVATIVE; DRUG DERIVATIVE; ISOTOPE; MELANIN; PHENYLALANINE; RADIOSENSITIZING AGENT;

AMELANOTIC MELANOMA; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN; BRAIN TUMOR; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; EXPERIMENTAL MELANOMA; METABOLISM; METHODOLOGY; MOUSE; NEUTRON CAPTURE THERAPY; PATHOLOGY;

ANIMALS; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN; BRAIN NEOPLASMS; ISOTOPES; MELANINS; MELANOMA, AMELANOTIC; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0035999740     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2002.00059.x     Document Type: Article

References (56)

1. Gamma knife radiosurgery for metastatic melanoma: An analysis of survival, outcome, and complication
2. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma
3. Malignant melanoma brain metastases - Review of Roswell Park Memorial Institute experience
4. Prognostic evaluation of intracranial metastasis in malignant melanoma
5. 10B molecule-melanoma cell interaction from in vitro to first clinical trial
6. 10B-compound
7. Advance in the control of human cutaneous primary and metastatic melanomas by thermal neutron capture therapy
8. Selective thermal neutron capture therapy of cancer cells using their specific metabolic activities-melanoma as prototype
9. 10B1-BPA fructose complex
10. Melanoma and nonmelanoma neutron capture therapy using gene therapy: Overview
11. Boron neutron capture therapy of intracranial melanoma using boronophenylalanine as a capture agent
12. A nude rat model for neutron capture therapy of human intracerebral melanoma
13. Radiation-induced dementia in patients cured of brain metastases
14. Radiation effects of boron neutron capture therapy on brain, skin, and eye of rats
15. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality
16. Boron neutron capture therapy for cancer
17. Will history repeat for boron capture therapy?
18. Boron-neutron capture therapy for tumors
19. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy
20. Boron neutron capture therapy. Clinical brain tumor studies
21. Recent study of boron neutron capture therapy for malignant brain tumor in Japan
22. Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: A cautionary note
23. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with and without blood-brain barrier disruption
24. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine
25. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent
26. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex
27. Boron neutron capture therapy for murine malignant gliomas
28. Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosiometry of sodium borocaptate in patients with gliomas
29. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory
30. Boron neutron capture therapy for glioblastoma multiforme: Interim results from the phase I/II dose-escalation studies
31. A clinicopathologic study of amelanotic melanoma
32. Amelanotic malignant melanoma
33. Amelanotic melanoma. The great masquerader
34. Melanoma from an unknown primary site and amelanotic melanoma
35. Fotemustine with or without Dacarbazine for brain metastases of malignant melanoma
36. Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases
37. Palliative radiotherapy for recurrent and metastatic malignant melanoma: Prognostic factors for tumor response and long-term outcome: A 20-year experience
38. Intracranial metastases from melanoma - Clinical features and treatment by accelerated fractionation
39. Metastatic melanoma in brain - Rapid treatment or large dose fractions
40. Surgical treatment of brain metastases in malignant melanoma
41. Surgical versus nonsurgical management of metastatic melanoma of the brain
42. Selective thermal neutron capture therapy of malignant melanoma using its specific metabolic activity
43. Current progress and future prospects for selective melanoma neutron capture therapy
44. Enhanced melanogenesis induced by tyrosine gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma
45. Brain meninges tumor formation by vivo-selected metastatic B16 melanoma variants in mice
46. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides
47. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
48. Inhibition of the growth of mouse melanoma by chlorpromazine
49. 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin
50. Experimental boron neutron capture therapy for melanoma. Systemic delivery of boron to melanotic and amelanotic melanoma
51. Capture of p-boronophenylalanine in malignant melanoma cells by complex formation with melanin monomers, DOPA, DHI and DHICA
52. 10B-Biodelivery Systems
53. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene
54. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy
55. The Harvard-MIT BNCT program - Overview of the clinical trials and translational research
56. 10B uptake by cell modulation